Cramer's Morning Take: Bristol Meyers & Eli Lilly 1/16/25

Jim and Jeff discuss why you should keep an eye on this biopharmaceutical company. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer